iPSC-based vaccine development

Khloris Biosciences, Inc. is a biotechnology company based in San Jose, California, dedicated to revolutionizing the medical treatment and prevention of cancer and other diseases by harnessing the immunotherapeutic potential of induced pluripotent stem cells (iPSCs) for drug discovery, vaccine and cell therapies. It states it is the first and only company to develop cancer vaccines using patient-derived iPSCs and a leader in using iPSC-derived cardiomyocytes for the treatment of cardiovascular diseases.

Read more

cell therapiesdrug discovery